Extendicare Inc. (TSE:EXE - Get Free Report) declared a jul 25 dividend on Thursday, July 31st, RTT News reports. Investors of record on Friday, August 15th will be given a dividend of 0.042 per share on Friday, August 15th. This represents a yield of 3.81%. The ex-dividend date is Thursday, July 31st.
Extendicare Stock Down 2.4%
EXE stock traded down C$0.32 on Friday, reaching C$12.91. 208,903 shares of the company traded hands, compared to its average volume of 184,664. Extendicare has a one year low of C$7.34 and a one year high of C$15.24. The company has a debt-to-equity ratio of 283.02, a current ratio of 0.62 and a quick ratio of 0.98. The company has a market cap of C$1.08 billion, a P/E ratio of 16.46 and a beta of 1.26. The firm has a fifty day simple moving average of C$14.06 and a 200-day simple moving average of C$12.75.
Analyst Upgrades and Downgrades
A number of analysts have commented on the company. National Bank Financial raised Extendicare to a "strong-buy" rating in a report on Wednesday. National Bankshares set a C$15.40 target price on Extendicare and gave the stock an "outperform" rating in a report on Thursday. TD Securities lifted their target price on Extendicare from C$13.00 to C$15.00 and gave the stock a "hold" rating in a report on Thursday, May 22nd. Finally, BMO Capital Markets lifted their target price on Extendicare from C$13.50 to C$14.50 in a report on Monday, May 12th. Three research analysts have rated the stock with a hold rating, one has issued a buy rating and one has assigned a strong buy rating to the company's stock. According to data from MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and a consensus price target of C$13.98.
Check Out Our Latest Report on Extendicare
About Extendicare
(
Get Free Report)
Extendicare Inc, operating solely in Canada, is the largest private-sector owner and operator of long-term care (LTC") homes and one of the largest private-sector providers of publicly funded home health care services.
Recommended Stories
Before you consider Extendicare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Extendicare wasn't on the list.
While Extendicare currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
